PARIS – 17 April 2018 – Advent International (“Advent”) and Sanofi have entered into exclusive negotiations under which Advent would acquire Zentiva, Sanofi’s European generics business for €1,919 million.  Advent’s offer is firm, binding and fully financed. Advent is a global investor, with over 25 years experience of investing in the healthcare sector. It has … Continue reading Advent International enters into exclusive negotiations to acquire Zentiva, Sanofi’s European generics business